Paul Calabresi Career Development Award for Clinical Oncology K12 Federal Grant

Home

RESEARCH

ARTICLES

RESOURCES

Government Jobs
Grant Forums

FAST GRANT SEARCH

FEDERAL GRANTS NEWSLETTER

Paul Calabresi Career Development Award for Clinical Oncology (K12)

The summary for the Paul Calabresi Career Development Award for Clinical Oncology (K12) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.

Federal Grant Title:	PAUL CALABRESI CAREER DEVELOPMENT AWARD FOR CLINICAL ONCOLOGY (K12)
Federal Agency Name:	National Institutes of Health
Program Name:	Cancer Treatment Research
Grant Categories:	Education Health
CFDA Number:	93.395
Funding Opportunity Number:	PAR-10-155
Posted Date:	Mar 26, 2010
Creation Date:	Mar 26, 2010
Original Application Deadline:	Jul 10, 2013
Current Application Deadline:	Jun 11, 2012
Archive Date:	Jul 11, 2012
Total Program Funding:	Information not provided
Maximum Federal Grant Award:	Information not provided
Minimum Federal Grant Award:	Information not provided
Expected Number of Awards:	Information not provided
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Grant Description: Purpose: This funding opportunity announcement (FOA) issued by the National Cancer Institute (NCI) encourages applications for institutional research career development (K12) programs from applicant organizations that propose to promote the training and career development of translational and clinical trials researchers. The purpose of the Paul Calabresi Career Development Award in Clinical Oncology (PCACO) K12 (NIH Institutional Research Career Development K12 grant mechanism) is to increase the number of clinicians (M.D.s, D.O.s, Pharm.D.s) and basic research scientists (Ph.D.s. or equivalents) who are trained to design and administer hypothesis-based pilot/Phase I, Phase II, and Phase III cancer therapeutic clinical trials in team research settings. A PCACO can support the research career development of clinicians only (single-track program) or clinicians and Ph.D. basic research scientists (dual-track program). Clinical and basic research scientists will collaborate and interact to expedite the translation of basic science research discoveries into patient-oriented therapeutic cancer research. The PCACO is not intended to train laboratory-based scientists whose research will be primarily focused upon the use of animal or other model systems. Mechanism of Support: This FOA will use the NIH Institutional Research Career Development K12 grant mechanism. K12 programs may not be transferred from one institution to another (See section VI.2). Funds Available and Anticipated Number of Awards: The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. Awards are renewable.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/par-10-155.html
Grant Announcement Contact: NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 Emphasis (ET-CTN) (UM1); • Planning for a National Center for Particle Beam Radiation Therapy Research (P20); • A Data Resource for Analyzing Blood and Marrow Transplants (Limited Competition U24); • Pediatric Phase 1/Pilot Consortium (Limited Competition UM1); • Childhood Cancer Survivor Study (CCSS)(Limited Competition U24); • Breast and Prostate Cancer Data Quality and Patterns of Care Study; • Consortium Therapeutic Studies of Primary Central Nervous System Malignancies in Adults; • National Cooperative Drug Discovery Groups for Cancer
More Grants from the National Institutes of Health: • NIAMS Clinical Trial Outcome Instrument Development Grant Program (U01); • Biophysical and Biomechanical Aspects of Embryonic Development (R01); • Biophysical and Biomechanical Aspects of Embryonic Development (R21); • Dual Purpose with Dual Benefit: Research in Biomedicine and Agriculture Using Agricultural...; • MARC Undergraduate Student Training in Academic Research (U-STAR) National Research Servic...